Production (Stage)
Medicale Corp.
MCLE
$0.1734
$0.01147.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.36% | 4.78% | 45.87% | 43.94% | 51.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.17% | 4.78% | 45.87% | 43.94% | 51.59% |
| Operating Income | 12.17% | -4.78% | -45.87% | -43.94% | -51.59% |
| Income Before Tax | 2.24% | -15.80% | -55.47% | -49.87% | -54.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.24% | -15.80% | -55.47% | -49.87% | -54.47% |
| Earnings from Discontinued Operations | -- | -- | -- | 100.00% | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.24% | -15.80% | -57.14% | -49.06% | -50.99% |
| EBIT | 12.17% | -4.78% | -45.87% | -43.94% | -51.59% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 2.20% | -17.28% | -61.29% | -53.23% | -54.24% |
| Normalized Basic EPS | 0.00% | -18.00% | -56.41% | -48.72% | -55.56% |
| EPS Diluted | 2.20% | -17.28% | -61.29% | -53.23% | -54.24% |
| Normalized Diluted EPS | 0.00% | -18.00% | -56.41% | -48.72% | -55.56% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |